Native-American contribution in Puerto Ricans is associated with a lower warfarin dose requirement
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: CLAUDIO, Karla (University of Puerto Rico, Pharmacology and Toxicology, San Juan, Puerto Rico)
- Co-author(s): Karla Claudio:|Carmen Cadilla:Biochemistry,University of Puerto Rico,San Juan,Puerto Rico|Jorge Duconge:Pharmaceutical Sciences,University of Puerto Rico,San Juan,Puerto Rico
Backgrounds: Warfarin is an oral anticoagulant that requires monitoring to avoid adverse drug reactions. Variability in warfarin dose requirements can be explained by clinical and genetic determinants. Puerto Ricans are admixed and heterogeneous having Caucasian, African and Native-American contributions.
Purpose: We hypothesized that admixture is.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.